Bernhard Schermer

Dr. Bernhard Schermer

Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in Cell
Verified
Journal Article
Closed access
PLPablo Landgraf
Pablo Landgraf
MRMirabela Rusu
Mirabela Rusu
RSRobert Sheridan
Robert Sheridan
ASAlain Sewer
Alain Sewer
NINicola Iovino
Nicola Iovino
TTThomas Tuschl
Thomas Tuschl

24 April 2005 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MSMatias Simons
Matias Simons
JGJoachim Gloy
Joachim Gloy
AGAthina Ganner
Athina Ganner
ABAxel Bullerkotte
Axel Bullerkotte
MBMikhail Bashkurov
Mikhail Bashkurov
GWGerd Walz
Gerd Walz
Cystic renal diseases are caused by mutations of proteins that share a unique subcellular localization: the primary cilium of tubular epithelial cells1. Mutations of the ciliary protein inversin cause nephronophthisis type II, an autosomal recessive cystic kidney disease characterized by extensive renal cysts, situs inversus and renal failure2. Here we report that inversin acts as a molecular switch between different Wnt signaling cascades. Inversin inhibits the canonical Wnt pathway by targeting cytoplasmic dishevelled (Dsh or Dvl1) for degradation; concomitantly, it is required for convergent extension movements in gastrulating Xenopus laevis embryos and elongation of animal cap explants, both regulated by noncanonical Wnt signaling. In zebrafish, the structurally related switch molecule diversin ameliorates renal cysts caused by the depletion of inversin, implying that an inhibition of canonical Wnt signaling is required for normal renal development. Fluid flow increases inversin levels in ciliated tubular epithelial cells and seems to regulate this crucial switch between Wnt signaling pathways during renal development.

20 July 2003 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EOEdgar A Otto
Edgar A Otto
Bernhard SchermerBernhard Schermer
Bernhard Schermer
TOTomoko Obara
Tomoko Obara
JOJohn F O'Toole
John F O'Toole
KHKarl S Hiller
Karl S Hiller
FHFriedhelm Hildebrandt
Friedhelm Hildebrandt

1 August 2012 in Cell
Verified
Journal Article
Closed access
MCMoumita Chaki
Moumita Chaki
RARannar Airik
Rannar Airik
AGAmiya K. Ghosh
Amiya K. Ghosh
RGRachel H. Giles
Rachel H. Giles
RCRui Chen
Rui Chen
FHFriedhelm Hildebrandt
Friedhelm Hildebrandt

1 April 2008 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CBCarsten Bergmann
Carsten Bergmann
MFManfred Fliegauf
Manfred Fliegauf
NBNadina Ortiz Brüchle
Nadina Ortiz Brüchle
VFValeska Frank
Valeska Frank
HOHeike Olbrich
Heike Olbrich
HOHeymut Omran
Heymut Omran

1 July 2003 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
THTobias B. Huber
Tobias B. Huber
BHBjürn Hartleben
Bjürn Hartleben
JKJeong Kim
Jeong Kim
MSMiriam Schmidts
Miriam Schmidts
Bernhard SchermerBernhard Schermer
Bernhard Schermer
TBThomas Benzing
Thomas Benzing
Mutations of NPHS1 or NPHS2, the genes encoding nephrin and podocin, as well as the targeted disruption of CD2-associated protein (CD2AP), lead to heavy proteinuria, suggesting that all three proteins are essential for the integrity of glomerular podocytes, the visceral glomerular epithelial cells of the kidney. It has been speculated that these proteins participate in common signaling pathways; however, it has remained unclear which signaling proteins are actually recruited by the slit diaphragm protein complex in vivo. We demonstrate that both nephrin and CD2AP interact with the p85 regulatory subunit of phosphoinositide 3-OH kinase (PI3K) in vivo, recruit PI3K to the plasma membrane, and, together with podocin, stimulate PI3K-dependent AKT signaling in podocytes. Using two-dimensional gel analysis in combination with a phosphoserine-specific antiserum, we demonstrate that the nephrin-induced AKT mediates phosphorylation of several target proteins in podocytes. One such target is Bad; its phosphorylation and inactivation by 14-3-3 protects podocytes against detachment-induced cell death, suggesting that the nephrin-CD2AP-mediated AKT activity can regulate complex biological programs. Our findings reveal a novel role for the slit diaphragm proteins nephrin, CD2AP, and podocin and demonstrate that these three proteins, in addition to their structural functions, initiate PI3K/AKT-dependent signal transduction in glomerular podocytes.